Quantitative analyses of variations in the injury of endothelial cells elicited by 11 isolates of Rickettsia rickettsii

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 4, 2001, Pages 788-796

  Eremeeva, M E ^a   Dasch, G A ^a   Silverman, D J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; LACTATE DEHYDROGENASE; PEROXIDE;

ANIMAL CELL; ARTICLE; BACTERIUM IDENTIFICATION; CELL DAMAGE; ENDOTHELIUM CELL; ENZYME RELEASE; HUMAN; HUMAN CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; STRAIN DIFFERENCE;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; ENDOTHELIUM; GLUTATHIONE; HUMANS; INTRACELLULAR FLUID; L-LACTATE DEHYDROGENASE; PEROXIDES; RICKETTSIA RICKETTSII; VERO CELLS;

EID: 0034964486     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.4.788-796.2001     Document Type: Article

References (62)

1. Reactivity of monoclonal antibodies to Rickettsia rickettsii with spotted fever and typhus group rickettsiae
2. Anti-genic heterogeneity in high- and low-virulence strains of Rickettsia rickettsii revealed by monoclonal antibodies
3. Biochemical and immunochemical analysis of Rickettsia rickettsii strains of various degrees of virulence
4. Properties of selected rickettsiae of the spotted fever group
5. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children - West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000
6. Biological and genetic characterization of Rickettsia sibirica strains isolated in the endemic area of the North Asian tick typhus
7. Nonpathogenic rickettsiae related to the spotted fever group isolated from ticks, Dermacentor variabilis and Dermacentor andersoni from eastern Montana
8. A toxic substance associated with the rickettsias of the spotted fever group
9. Spotted fever vaccine; potency assay by direct challenge of vaccinated mice with toxin of Rickettsia rickettsii
10. Immunologic relationships among the spotted fever group of rickettsias determined by toxin neutralization tests in mice with convalescent animal serums
11. A review of Rocky Mountain spotted fever (tick-borne typhus), its agent, and its tick vectors in the United States
12. Mechanisms of transovarial infection of spotted fever rickettsiae in ticks
13. A new spotted fever group rickettsia from the lone star tick, Amblyomma americanum
14. Rickettsia rhipicephali, a new spotted fever group rickettsia from the brown dog tick, Rhipicephalus sanguineus
15. An apparent outbreak of rickettsial illness in Costa Rica, 1974
16. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay
17. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever
18. Viability measurements in mammalian systems
19. National surveillance for Rocky Mountain spotted fever, 1981-1992: Epidemiologic summary and evaluation of risk factors for fatal outcome
20. Epidemiological aspects of the Brazilian spotted fever: Seasonal activity of ticks collected in an endemic area in Sao Paulo, Brazil
21. Permanent cell line expressing human factor VIII-related antigen established by hybridization
22. Interaction of rickettsiae with eukaryotic cells. Adhesion, entry, intracellular growth, and host cell responses
23. Rickettsia rickettsii infection of human endothelial cells: Oxidative injury and reorganization of cytoskeleton
24. Effects of the antioxidant alpha-lipoic acid on human umbilical vein endothelial cells infected with Rickettsia rickettsii
25. Rickettsia rickettsii infection of the EA.hy 926 endothelial cell line: Morphological response to infection and evidence for oxidative injury
26. Differentiation among spotted fever group rickettsia species by analysis of restriction fragment length polymorphism of PCR-amplified DNA
27. Fatal cases of Rocky Mountain spotted fever in the United States, 1981-1988
28. Ecological study of Rocky Mountain spotted fever in Costa Rica
29. DNA typing of rickettsiae in naturally infected ticks using a polymerase chain reaction/restriction fragment length polymorphism system
30. Mechanisms of immunity in typhus infections. II. Multiplication of typhus rickettsiae in human macrophage cell cultures in the nonimmune system: Influence of virulence of rickettsial strains and of chloramphenicol
31. Staining rickettsiae in yolk sac culture
32. Fatal Rocky Mountain spotted fever
33. Directional actin polymerization associated with spotted fever group rickettsia infection of Vero cells
34. Rocky Mountain spotted fever: Clinical, laboratory, and epidemiological features of 262 cases
35. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever
36. Rocky Mountain spotted (and spotless) fever
37. Comparison of acridine orange and Gram stains for detection of microorganisms in cerebrospinal fluid and other clinical specimens
38. Isolation and characterization of Rocky Mountain spotted fever rickettsiae from the rabbit tick Haemaphysalis leporis-palustris Packard
39. Observations on an infectious agent from Amblyomma maculatum
40. A spotted fever in Tobia, Colombia. Preliminary report
41. Rickettsia bellii sp. nov.: A tick-borne rickettsia, widely distributed in the United States, that is distinct from the spotted fever and typhus biogroups
42. Serotypes of spotted fever group rickettsiae isolated from Dermacentor andersoni (Stiles) ticks in Western Montana
43. Serologic typing of rickettsiae of the spotted fever group by microimmunofluorescence
44. Variation in virulence of "Rickettsia rickettsii" under natural and experimental conditions
45. The epidemiology of Rocky Mountain spotted fever. II. Studies on the biological survival mechanism of Rickettsia rickettsii
46. The epidemiology of Rocky Mountain spotted fever. I. The characterization of strain virulence of Rickettsia rickettsii
47. Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes
48. Evidence of rickettsial spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina
49. Rocky Mountain spotted fever
50. A scheme for the colorimetric determination of microgram amounts of thiols
51. Brazilian spotted fever in Espirito Santo, Brazil: Description of a focus of infection in a new endemic region
52. Rocky Mountain "spotless" and "almost spotless" fever: A wolf in sheep's clothing
53. Oxidative cell injury and spotted fever group rickettsiae
54. Measurement of protein using bicinchoninic acid
55. The ecology of ticks transmitting Rocky Mountain spotted fever in a study area in Virginia
56. Rocky Mountain spotted fever: Infectivity of fasting and recently fed ticks
57. Differentiation between virulent and avirulent strains of Rickettsia prowazekii by macrophage-like cell lines
58. Rocky Mountain spotted fever: Clinical signs, symptoms, and pathophysiology
59. Phylogenetic placement of rickettsiae from the ticks Amblyomma americanum and Ixodes scapularis
60. Plaque formation in tissue cultures by Rickettsia rickettsii isolated directly from whole blood and tick hemolymph
61. Infection cycle of Rickettsia rickettsii in chicken embryo and L-929 cells in culture
62. Serologic study of the prevalence of rickettsiosis in Yucatan: Evidence for a prevalent spotted fever group rickettsiosis